Pharmaceuticals & Healthcare Q4 Round-Up

 

BMI View: The global pharmaceutical market will be increasingly influenced by a wide spectrum of stakeholders. Regulators are seeking ways to accelerate approval process. Governments are constantly balancing demands for new treatments with budgetary constraints. Charities and multilateral organisations are widening medicine access to those on low incomes. Patient groups are encouraging research into innovative therapeutics to reduce disease burdens. Pharmaceutical companies need to develop close ties with these stakeholders and work consistently to build trust.

Pharmaceuticals & Healthcare Q4 Round-Up
Product Price
$595.00

The Pharmaceuticals & Healthcare Q4 Round-Up features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Pharmaceuticals & Healthcare Q4 Round-Up provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Global pharmaceutical and healthcare industry.